Roles of skeletal muscle-derived exosomes in osteoporosis
He Y., Wang Y., Weng K., Weng X., Yuan Y.
Narrative Review, published in J Transl Med (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- J Transl Med (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41254685
- PMCID
- PMC12625326
- DOI
- 10.1186/s12967-025-07315-3
Abstract (original English)
Bone maintains a relatively stable bone mass by balancing bone formation and resorption. The development of osteoporosis is closely associated with the disruption of this balance. Muscles and bones, integral components of the musculoskeletal system, are functionally interconnected, and the onset of osteoporosis is frequently linked to the decline in skeletal muscle function. Exosomes play a crucial role in facilitating chemical information exchange between muscles and bones. This study aims to elucidate the effects of skeletal muscle-derived exosomes on bone formation and resorption, investigate their therapeutic potential for osteoporosis, and propose novel strategies for osteoporosis treatment and targeted drug development. The Translational Potential of this Article: This study investigated the potential of skeletal muscle-derived exosomes in osteoporosis treatment, elucidating their critical role in modulating bone formation and resorption. By clarifying the interaction mechanisms between muscle and bone mediated by exosomes, this research laid a theoretical foundation for novel therapeutic strategies. Therapies based on serve as more targeted and efficient interventions with fewer side effects, thereby advancing the field of bone tissue engineering and offering new prospects for the prevention and management of osteoporosis.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.